NCT05209152 2025-07-14AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic LeukemiaAmgenPhase 1 Terminated7 enrolled 16 charts
NCT03797261 2021-12-07A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic MalignanciesAbbViePhase 1 Terminated9 enrolled